Medical Weight Loss for Charlotte, North Carolina Residents

Charlotte, North Carolina residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Charlotte through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of North Carolina, including Charlotte: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Charlotte Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Charlotte patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in North Carolina gets.

Charlotte is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Charlotte address.

Your zip code in Charlotte, North Carolina does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout Uptown, NoDa, South End, Dilworth, Ballantyne, and the greater Charlotte area. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Charlotte you are.

Telehealth lets you skip the commute entirely, so the time you would have spent driving across Charlotte goes straight into starting your program. Between Klarna, Affirm, and HSA or FSA cards, Charlotte patients have several ways to handle the $119 review and ongoing medication payments. Across fast-growing North Carolina, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to travel for a visit.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Charlotte telehealth patients.

How Telehealth Works for Charlotte

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Charlotte address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Charlotte

Can I start with New Hope Weight Loss if I am located in Charlotte?

Yes, you can start from Charlotte right away. Our physical clinic is in Costa Mesa, California, and we deliver care to Charlotte, North Carolina by telehealth. A video consultation with Dr. Anjmun Sharma reviews your medical history and confirms your fit for compounded semaglutide or tirzepatide.

Do appointments require me to leave Charlotte?

They do not. Every appointment is handled by telehealth, so Charlotte patients never leave home for the doctor. You connect with Dr. Sharma online, and approved medication is sent to your Charlotte address in cold-pack packaging that shields it from heat during shipping.

What is the pricing for Charlotte residents?

You will pay $119 for the physician visit. Semaglutide starts at $166 a month or $499 for the 90-day option, and tirzepatide at $233 a month. The medication carries a separate charge. HSA, FSA, Klarna, and Affirm are all accepted, and there is no distance surcharge for Charlotte.

What areas of Charlotte do you serve?

We serve patients from across Charlotte by telehealth, including Uptown, NoDa, South End, Dilworth, Ballantyne, and the greater Charlotte area.

Is telehealth treatment as thorough as an in-person visit for Charlotte patients?

Yes. Charlotte patients get the same physician review by Dr. Sharma, the same contraindication screening, the same dose titration, and the same follow-up schedule as an in-person patient. The visit simply happens by secure video.

Charlotte Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Charlotte, North Carolina by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.